Growth Metrics

Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)

Cellebrite DI's Total Non-Current Liabilities history spans 6 years, with the latest figure at $84.9 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 43.75% to $84.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84.9 million through Dec 2025, up 43.75% year-over-year, with the annual reading at $84.9 million for FY2025, 43.75% up from the prior year.
  • Total Non-Current Liabilities came in at $84.9 million for Q4 2025, up from $69.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $359.5 million in Q2 2024 to a low of $41.4 million in Q3 2021.
  • The 5-year median for Total Non-Current Liabilities is $124.8 million (2022), against an average of $149.8 million.
  • Year-over-year, Total Non-Current Liabilities soared 466.45% in 2021 and then plummeted 81.76% in 2025.
  • Cellebrite DI's Total Non-Current Liabilities stood at $226.6 million in 2021, then plummeted by 46.3% to $121.7 million in 2022, then soared by 101.27% to $244.8 million in 2023, then tumbled by 75.89% to $59.0 million in 2024, then surged by 43.75% to $84.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Total Non-Current Liabilities are $84.9 million (Q4 2025), $69.7 million (Q3 2025), and $69.0 million (Q2 2025).